Search global stocks & ETFs...Ctrl K
Learn Mode
ELV logo

ELV - Elevance Health Inc

197


$389.03

-$13.63 (-3.385%)
At close: 6/2/26, 8:00 PM
Stock Unlock LogoScore

3.18/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
ELV
Valuation Score
View as %

Stock Unlock Logo
Stock Unlock
$272$407JunAugOctDecFebApr

1D
1W
1M
YTD
1Y
3Y
5Y
Max

Stock Profile
  • Market Cap
    $84.36B
  • Industry
    Health Care
  • EPS (TTM)
    $23.78
  • P/E (TTM)
    16.09
  • Div & Yield
    $6.88 (1.77%)
  • FCF Payout Ratio
    23.13%
  • P/S (TTM)
    0.42
  • P/B
    1.92
  • Diluted Shares
    220.40M
  • Ex-Dividend
    2026-06-10
  • Next Earnings
    07-15
  • Forward P/E
    14.59
  • Payout Ratio
    28.45%
  • P/FCF (TTM)
    13.08
  • FCF Yield
    7.65%
  • Earnings Yield
    6.22%
  • 52 Week Range
    $273.71$408.00
3.18
Average
Elevance Health Inc has grown revenue at 9.44% over the past year, which suggests sales are increasing. Also, it has seen its diluted average shares outstanding decrease by -2.99% over the past year, which suggests the company is buying back shares.
Valuation Model
Key Score
5.00
Very Good
Management
5.00
Very Good

Growth
1.00
Very Bad

Profitability
4.00
Good
Fin. Health
4.00
Good

Dividends
5.00
Very Good

Analyst
4.00
Good
Insider Transactions
Explore Insider Tab
Buy
Sell
201020122014201620182020202220242026$0$30M$60M$90M$120M
Market News
Page 1 of 21
Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-20 16:11:33


Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-05-19 16:25:49


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:33:51


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:16:22


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:15:47


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:15:18


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:14:44


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:14:01


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:12:42


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:12:15


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:11:33


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-15 16:10:47

Page 1 of 21
Revenue
Earnings
Free Cash Flow
2022202320242025$0$50B$100B$150B$200B
Price Targets
Go to Analyst Tab
These are one year price targets for: 2027-05-11
High:
$516.02
32.6%
Avg:
$399.68
2.7%
Low:
$334.31
-14.1%
(% change is relative to the current stock price: $389.03)
Analyst Recommendations
Go to Analyst Tab
3.76
Good
21%
Strong Buy (6)
34%
Buy (10)
45%
Hold (13)
0%
Sell (0)
0%
Strong Sell (0)
About
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 96,129 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
  • IPO Date
    2001-10-30
  • Industry
    Health Care
  • Total Employees
    96,129
  • Exchange
    New York Stock Exchange, Inc.
  • Reporting Currency
    USD
  • GICS
    Health Care Providers & Services
  • GICS Sub
    Managed Health Care
  • GICS Sector
    Health Care
  • GICS Group
    Health Care Equipment & Services